The mission of the Harvey L. Neiman Health Policy Institute® is to establish foundational evidence for health policy and radiology practice that promotes the effective and efficient use of health care resources and improves patient care.
A new Harvey L. Neiman Health Policy Institute (HPI) and American College of Radiology® (ACR®) Data Science Institute (DSI) study projects that new U.S. Food and Drug Administration (FDA)-approved artificial intelligence (AI) medical imaging products will increase five-fold by 2035. Read More
The Harvey L. Neiman Health Policy Institute has announced the release of Neiman Almanac 2.0. The Neiman Almanac is an online public resource that provides imaging-focused Medicare data back to 2004, including national and state trends in spending and utilization. Read More
The mission of the Harvey L. Neiman Health Policy Institute® is to establish foundational evidence for health policy and radiology practice that promotes the effective and efficient use of health care resources and improves patient care.
Read More
October 16, 2023 in Press Releases
A new Harvey L. Neiman Health Policy Institute (HPI) and American College of Radiology® (ACR®) Data Science Institute (DSI) study projects that new U.S. Food and Drug Administration (FDA)-approved artificial intelligence (AI) medical imaging products will increase five-fold by 2035. Read More
Medical imaging accounts for 85% of digital health’s venture capital funding. As funding grows, it is expected that artificial intelligence (AI) products will increase commensurately. The study’s objective is to project the number of new AI products given the statistical association between historical funding and FDA-approved AI products. Full Article
October 11, 2023 in Press Releases
The Harvey L. Neiman Health Policy Institute has announced the release of Neiman Almanac 2.0. The Neiman Almanac is an online public resource that provides imaging-focused Medicare data back to 2004, including national and state trends in spending and utilization. Read More
October 1, 2023 in Policy Briefs
The ACP now says CTC shouldn’t be used for primary colon cancer screening. USPSTF recommends CTC. Commercial carriers pay for it, but Medicare doesn’t. Why the conflicting policies, and what can the Neiman Health Policy Institute do to help? Read the full ACR Bulletin October 2023 Column
September 5, 2023 in Press Releases
A new Harvey L. Neiman Health Policy Institute study found that 33% to 46% of imaging studies interpreted by radiologists do not have any related imaging studies in the year following the index imaging event. As such, these ‘one-off events’ are not good candidates for reimbursement through episode-based payment models. Read More